H.C. Wainwright Starts Moleculin Biotech (MBRX) at Buy

December 14, 2023 6:05 AM EST Send to a Friend
H.C. Wainwright analyst Vernon Bernardino initiates coverage on Moleculin Biotech (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login